Improving Outcomes for People With Cancer By Developing TTX-030, A First- In-Class, Anti-CD39 Antibody
Time: 10:30 am
day: Day Two
Details:
- Explore translational practices and how they can be improved for greater confidence upon reaching the clinic
- Using novel approaches to inform clinical decision making
